[Performance parameters and pathogen detection in pig groups differently vaccinated with respect to Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae]. / Leistungsparameter und Erregernachweise in unterschiedlich geimpften Tiergruppen in Bezug auf das Porzine Circovirus Typ 2 und Mycoplasma hyopneumoniae.

OBJECTIVE: Respiratory diseases, mostly multifactorial, cause problems in pig farms worldwide. Next to infectious agents, such as Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyopneumoniae) management, housing, and environmental factors are decisive for the development of disease. In a conventional, closed swine farm in Lower Saxony, Germany, which did not vaccinate against PCV2, the effect of an implementation of PCV2 vaccination (Suvaxyn® Circo + MH RTU) onto animal health was evaluated. In addition, the effect of this combination vaccine was assessed in comparison to simultaneous administration of mono-vaccines against PCV2 and M. hyopneumoniae. MATERIAL AND METHOD: In a two-phase trial, 524 (phase 1) or 521 (phase 2) clinically healthy piglets were included at the first week of life. In the first phase, performance parameters were compared in animals vaccinated against M. hyopneumoniae only (group A) or vaccinated against PCV2 and M. hyopneumoniae (group B). In phase 2, vaccination against PCV2 and M. hyopneumoniae with different vaccines were compared (groups C and D). Performance parameters included lifetime animal losses, daily weight gains during suckling, weaning and fattening, and randomly sampled pathogen loads in serum (PCV2) or tracheobronchial secretions (M. hyopneumoniae). In addition, an assessment of the lungs was performed after slaughter. RESULTS: In the first phase, it was shown that the group vaccinated against PCV2 (Group B: Suvaxyn® Circo + MH RTU) had higher daily growth rates during the fattening period (+ 37 g, p = 0.012) as well as during the complete period (+ 16 g, p = 0.013) in comparison to the group without PCV2 vaccination (Group A). In group A a significantly higher proportion of animals showed a PCV2 viremia. In the second phase, it was shown that group D was not inferior to the established vaccination regiment of group C. In fattening pigs in week 22 of life, detection rates for M. hyopneumoniae in tracheobronchial secretions were in the range of 27-80 % irrespective of the vaccination group. CONCLUSION: Vaccination against PCV2 leads to improved animal health and higher daily weight gains. CLINICAL RELEVANCE: The combined vaccine studied here provides farmers and veterinarians with an additional option for the improvement of animal health in pig production.

[Comparison of sample materials for the detection of infection with porcine reproductive and respiratory syndrome virus]. / Vergleich von Probenmaterialien zur Früherkennung einer Infektion mit dem Virus des Porzinen Reproduktiven und Respiratorischen Syndroms.

OBJECTIVE: In breeding farms with a high health status, pigs are frequently sampled using invasive methods (i. e. blood sampling). The aim of the present study was to evaluate less invasive methods concerning their suitability for an early detection of the infection with the porcine reproductive and respiratory syndrome virus (PRRSV). MATERIAL AND METHODS: Blood and saliva swabs, chewing rope derived oral fluids and serum samples were used for PRRSV-1 and PRRSV-2 detection via PCR. 19 gilts were repeatedly sampled following intramuscular or intranasal vaccination with live-attenuated vaccines containing PRRSV-1 or -2. Swabs were either moistened with saliva from the mouth mucosa or with blood from the ear veins following superficial needle puncture. Serum samples were taken via puncture of the V. jugularis externa. Chewing ropes served for a means of oral fluid sampling and were kept hanging in the barn at the pigs' head height for 30 minutes. RESULTS: All animals were negative for PRRSV at the time of vaccination (sampling point 0). In serum samples, the first virus detection was achieved 12 hours following vaccination (p. vacc.). From day 4 p. vacc. on all animals were viremic and from day 10 p. vacc. on the percentage of positive animals decreased. The first detection of PRRSV in GenoTube® blood swabs was possible 36 hours p. vacc. Examination of the eSwab® blood swab resulted in only one positive finding within the entire testing period. In the saliva samples, first detection of PRRSV was possible on day 5 p. vacc. CONCLUSION AND CLINICAL RELEVANCE: This study demonstrates that serum samples taken from the V. jugularis externa may be considered as the gold standard for diagnostic of PRRSV viremia. Detection rates in serum were higher than in the alternative sample types. However, since sample collection procedures and processing of the alternative sample materials offer clear advantages with regard to welfare, practical handling and logistics, further attempts are warranted in order to improve these methods. Based on the presented results, the described method using eSwab® blood sampling does not represent a satisfactory alternative approach for the detection of early PRRSV infection. Future application of this method warrants further improvement of its diagnostic efficacy.